Service agreement for cytoflex s machine

Active Awarded Last action

Contract number
75N91026F00001
Awardee
Awarding agency
Obligated
$20,554

Award facts

Opportunity
Contract value 100% obligated
$20,554.00 Current and potential, with all options
Completion date 69% complete
Current and potential, with all options
NAICS code
811210 Electronic and Precision Equipment Repair and Maintenance
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Brea, CA 92821, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, awarded a Delivery Order valued at $20,554 to Beckman Coulter, Inc. on February 11, 2026, for a service agreement covering a CytoFlex S flow cytometry machine. The contract is firm fixed price with no small business set-aside designation and is scheduled for completion by February 10, 2027. Performance will take place at Beckman Coulter's facility in Brea, California. This delivery order likely falls under one of Beckman Coulter's existing Indefinite Delivery Contracts, such as the $6 million IDC awarded by the Office of Logistics and Acquisition Operations for biomedical laboratory equipment, maintenance, and related services that supports flow cytometry and other specialized laboratory instrumentation across federal agencies.

Beckman Coulter, a subsidiary of Danaher Corporation and a large global manufacturer of biomedical testing equipment and laboratory instruments, is a longstanding federal vendor with extensive experience providing flow cytometry systems, maintenance services, reagents, and technical support to the NCI and other NIH institutes. The CytoFlex S service agreement represents part of Beckman Coulter's broader federal portfolio, which encompasses preventative maintenance, repair, calibration, and consumable supply provision for specialized laboratory equipment across multiple civilian and defense agencies. The company's strategic position as a preferred provider of advanced diagnostic and research technologies with limited competitive alternatives is reflected in its numerous prime contract awards across the federal government with no small business set-asides.

Quick answers

Who was awarded contract 75N91026F00001?

75N91026F00001 was awarded to Beckman Coulter, Inc. by National Cancer Institute (National Institutes of Health) on February 11, 2026.

How much is contract 75N91026F00001 worth?

The government has obligated $20,554 on 75N91026F00001.

Is contract 75N91026F00001 an order under another contract?

Yes. 75N91026F00001 is a delivery order under 75N98024D00007, an indefinite delivery contract.

Was contract 75N91026F00001 competed?

The extent of competition for 75N91026F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award